AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Cancer patients experience tumor regression despite low T cell levels.
2003 MAY 14 - (NewsRx.com & NewsRx.net) -- Cancer patients can experience tumor regression despite low titers of antigen-specific T cells.
According to a study from Belgium, "Following vaccination with defined tumor antigens that are recognized by T cells, a small proportion of cancer patients display tumor regressions."
"Several reports describe anti-vaccine T-cell responses, evaluated with a variety of methods, for example, by assessing T-cell function or expression of specific TCR," said Pierre G. Coulie and Pierre van der Bruggen at the University of Louvain in Brussels. "However, a correlation between these T-cell responses and the tumor regressions has not yet been established."
The researchers concluded, "It appears that some patients display tumor regression with an unexpectedly low ...
- Turning Malignancy Into Autoimmune Disease Two Of 12 Colon Cancer Patients Gain...
- Magazine article from: BIOWORLD Today Leff, David N. August 17, 2001 700+ words
...immunologists at Stanford University announced that they had deliberately turned tumors in a dozen terminal-stage colon-cancer patients into autoimmune disease targets. Their contrarian strategy produced two remissions. The Proceedings of the National Academy...
- ARIAD Reports Tumor Regression With AP23573 As a Single Agent in Patients with...
- Press release article from: Business Wire September 30, 2004 700+ words
...agent, showing documented tumor regression in patients with advanced...patients in the two trials, tumor regression was demonstrated in 9 patients...AP23573 also produced tumor regression in 2 patients, both with...and a common finding in cancer patients on various ...
- pSivida Limited Reports Positive Phase IIa Trial Results in Liver Cancer;...
- Press release article from: Business Wire February 14, 2005 700+ words
...inoperable primary liver cancer patients continues to show excellent...is safe and effective in tumor regression with increased efficacy...treatment, revealed an average tumor regression by volume of 80% as determined...the significant level of tumor regression achieved ...
- EntreMed's ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model.
- Newspaper article from: Angiogenesis Weekly November 7, 2008 700+ words
...of 100 mg/kg/day, and tumor regression was observed at doses of 200...a single agent, including tumor regression, in multiple xenograft models...clinical study in advanced cancer patients. Dr. Mark R. Bray, Vice...
- Mechanism for T cell association with tumor regression elucidated.
- Newspaper article from: Virus Weekly July 20, 2004 700+ words
...mechanism for T cell association with tumor regression has been elucidated. "The dramatic tumor regression observed following adoptive T cell...played a role in the nearly complete tumor regression that was observed following this treatment...
- EntreMed Announces its Aurora Kinase Inhibitor Induces Tumor Regression in...
- Press release article from: M2 Presswire June 1, 2007 700+ words
...its Aurora Kinase Inhibitor Induces Tumor Regression in Preclinical Models(C)1994...administered ENMD-981693 induced tumor regression with minimal toxicity in a preclinical...This activity is consistent with tumor regression induced by ENMD-981693 in preclinical...
- EntreMed's Aurora Kinase Inhibitor Induces Tumor Regression in Preclinical...
- Press release article from: PR Newswire June 1, 2007 700+ words
...administered ENMD-981693 induced tumor regression with minimal toxicity in a preclinical...This activity is consistent with tumor regression induced by ENMD-981693 in preclinical...981693 has been shown to induce tumor regression in multiple preclinical models, which...
- Novel Orally-Active Kinase Inhibitor Induces Tumor Regression in Multiple...
- Press release article from: PR Newswire December 11, 2006 700+ words
...doses. ENMD-981693 induced strong tumor regression with minimal toxic effects when administered...This activity is consistent with tumor regression induced by ENMD-981693 in animal...981693 has been shown to induce tumor regression at well- tolerated doses in multiple...